Nan-Kai Wang, MD, PhD, is Assistant Professor of Ophthalmic Sciences (in Ophthalmology). His research interest focuses on mitochondria function, which is involved in cellular metabolism and apoptosis. His overall research goal is to develop therapies for retinitis pigmentosa and retinal ganglion cell (RGC) degeneration through mitochondrial reprogramming. Wang received his M.D. at National Taiwan University. After completing his residency in ophthalmology and vitreoretinal fellowship at Chang Gung Memorial Hospital in Taiwan, Wang was invited to join as a faculty member of the Vitreoretinal team in the same institute, where he established himself as an independent physician-scientist. He conducted projects in genetics in hereditary retinal dystrophies, juvenile-onset diabetes, and myopia, funded by several grants in Taiwan. In recognition of his productivity and the importance of his work, Wang received an accelerated advancement to the rank of Associate Professor in Taiwan. On an international level, Wang was elected as an active member of the Macula Society in 2014.